Author Affiliations: Robert Wood Johnson Foundation Clinical Scholars Program, Yale University, New Haven, Connecticut (Drs Fox and Gross); Department of Health Behavior and Health Education, University of Michigan School of Public Health, and Division of General Internal Medicine, University of Michigan Medical School, Ann Arbor (Dr Zikmund-Fisher); and Division of General Internal Medicine and Cancer Outcomes Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine, and Yale Comprehensive Cancer Center (Dr Gross).
The benefit of mammography for breast cancer screening among women older than 75 years is unclear owing to competing comorbidity and lack of evidence.1 In this area of uncertainty, an individualized approach to cancer screening that considers a patient's age, health status, and preferences is desirable.2 Such an approach would optimize screening practices and avoid screening women unlikely to benefit; a phenomenon that may apply to 2 of every 5 mammograms in this age group.3
When considering cancer screening, shared decision making is particularly important for older persons. In the absence of evidence-based recommendations, patients should have the opportunity to discuss the pros and cons of screening with their health care providers. Individualizing cancer screening in this age group requires a balanced patient-provider conversation that considers patients' overall health, communicates the potential benefits and adverse outcomes of screening, and elicits patients' preferences. We conducted this study to (1) describe the patient-provider conversation surrounding screening mammography among women older than 75 years and (2) evaluate if the patients' perceptions of their health care providers' screening recommendations varied according to age and health status.
We analyzed responses from the breast cancer screening module within the DECISIONS study, a national random-digit dial telephone survey with a 51% weighted response rate, conducted between 2006 and 2007.4 Respondents were limited to those 40 years and older without a history of breast cancer. A complete description of the survey design, including questions, response scales, and survey weights, is available from the Inter-University Consortium for Political and Social Research.4
To account for the sampling design, weighted frequency comparisons were performed using PROC SURVEYFREQ (SAS version 9.2; SAS Institute Inc). These analyses compared the frequency with which women discussed reasons to have or not have a mammogram, whether their preferences were elicited, and if a physician recommendation was given across age (40-74 vs ≥75 years) and self-reported health (excellent to good vs fair to poor) groups.
Responses from 873 women were included; 10% were 75 years or older. Most women were white, had at least a high school education, and were insured. Annual income, self-reported health status, and perceived risk of breast cancer decreased with age.
Women 75 years and older were less likely to discuss reasons to have a mammogram than younger women (40-74 years, 92%, vs ≥75 years, 83%; P = .02). A discussion that included reasons not to have a mammogram (19% vs 21%; P = .81) or one that elicited a patient's screening preference (38% vs 39%; P = .93) was relatively uncommon across both age groups. The receipt of any health care provider recommendation did not vary by age (79% vs 78%; P = .92) and was nearly always in favor of screening (99% vs 98%; P = .35; Table).
Compared with women in excellent-good health, women in fair-poor health were as likely to discuss reasons to have a mammogram (fair to poor, 94%, vs excellent to good, 91%; P = .32) or not have a mammogram (12% vs 21%; P = .09). A discussion that elicited a patient's screening preference (41% vs 38%; P = .64) or the receipt of a recommendation to undergo screening (99% vs 98%; P = .35) did not vary according to health status. When restricting this analysis to patients 75 years and older and evaluating these same end points across health status groups, similar results were observed.
Older patients are concerned about how screening and treatment will or will not affect their overall survival and independence.5 Unfortunately, we found that health care providers were less likely to discuss the reasons to undergo screening mammography with women 75 years or older and infrequently discussed reasons to not undergo mammography. Furthermore, only 39% believed that their health care providers sought their preferences about screening mammography. This imbalance in counseling was mirrored in health care providers' universally recommending screening mammography across health or age groups.
This failure to discuss “the good with the bad” of mammographic screening or consider a patient's likelihood to benefit when making recommendations could lead to screening women unlikely to benefit. Studies based on the National Health Interview Survey and regional populations suggest that women older than 74 years receive screening mammograms despite poor health status and may account for up to 40% of women who receive screening in this age group.6 Lack of clinical time, sensitivity of the discussion, and the position of mammography in popular culture may all contribute to a suboptimal patient-provider discussion surrounding mammography use or screening cessation.7
To address this issue, we must create patient-centered decision aids that facilitate an informed cancer screening discussion between patients and health care providers. System-level incentives should allow time for dedicated wellness visits, include electronic reminders to discuss rather than order screening tests, and involve a more thoughtful tailoring of performance measures toward appropriate, patient-centered testing.8
Correspondence: Dr Fox, Robert Wood Johnson Foundation Clinical Scholars Program, Yale University School of Medicine, 333 Cedar St, Room SHM 1E-61, PO Box 208088, New Haven, CT 06520-8088 (email@example.com).
Author Contributions:Study concept and design: Fox and Gross. Acquisition of data: Zikmund-Fisher. Analysis and interpretation of data: Fox and Zikmund-Fisher. Drafting of the manuscript: Fox. Critical revision of the manuscript for important intellectual content: Zikmund-Fisher and Gross. Statistical analysis: Fox. Study supervision: Gross.
Financial Disclosure: None reported.
Funding/Support: Drs Fox and Gross are involved with the Clinical Scholar's Program, which is supported by the Robert Wood Johnson Foundation. Dr Zikmund-Fisher is supported by a career development award from the American Cancer Society (MRSG-06-130-01-CPPB). The DECISIONS study was funded by the Foundation for Informed Medical Decision Making.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature
Chapter 22.2. Decision Making and the Patient
Users' Guides to the Medical Literature
The Role of Costs in Clinical Decision Making Remains Controversial
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.